- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02200926
Non-pharmacological Treatment for Essential Isolated Systolic Hypertension in Elderly
Effects of Slow Loaded and Unloaded Breathing Training
The previous studies used the slow loaded breathing device for breathing training (Jones et al., 2010). It has been shown that slow loaded breathing training can reduce resting blood pressure and heart rate in essential hypertensive patients. However, this has not been studied in elderly with essential isolated systolic hypertensive patients. Not only highest prevalence of hypertension in Thailand was found in elderly but also physiological changes in the elderly are cause of interest in this special population. It has many advantages to use a slow loaded breathing training in elderly people. Firstly, it is low technology and easily implemented at home. Secondly, it can be practiced almost anytime and anywhere. Thirdly, the orthopedic complications of slow loaded breathing training are minimal. Finally, slow loaded breathing training may be enhancing cardiopulmonary function and other fitness traits, but it out of scope of this study. Moreover, slow loaded breathing exercise by itself should not result in any metabolic adaptation of skeletal muscles, such as the forearm, which had not been trained. If slow loaded breathing training modified some central component of the pressor reflex pathway in a way that single muscle training might work, as suggested above, then loaded breathing training would have a modulating effect on the pressor responses of muscles that had not been trained.
We, therefore, aim to study the effect of slow loaded breathing training by using Breathmax on blood pressure at rest and exercise in elderly with essential isolated systolic hypertension and also investigate the autonomic function and others that may be involved with the changed blood pressure in elderly with essential isolated systolic hypertension. We hypothesized that slow loaded and unloaded breathing training could reduce resting and exercising blood pressure in elderly with essential isolated systolic hypertension.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All subjects will be trained for blood pressure and heart rate measurement at home by using a digital arm blood pressure monitoring for 2 weeks control periods before start breathing training. After 2 weeks, subjects in both breathing training groups will trained to inspire deeply against the resistance setting by using Breathmax at the loaded of 18 centimeter of water (cmH2O) and 0 cmH2O (no resistance) with breathing frequency control at 6 breaths/minute in loaded breathing (LB) and unloaded breathing (ULB) group, respectively. They will rest for 5 seconds after every 6 deep breathing. Breathing pattern will be controlled at duty cycle of 0.4 (inspiratory time = 4 sec and total respiratory time = 10 sec). The paced breathing will be practice using metronome at the laboratory until the subjects can do independently without metronome. The breathing was performed normally in control groups (C). The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
After 8 weeks of breathing training, the sustainability of breathing training effect will be assessed. Subjects in both breathing training groups (LB and ULB) will be stop breathing training with Breathmax and change to breathing normally. In contrast with the subjects in control group, they will be divided to 2 subgroups. The first subgroup performed loaded breathing training at the loaded of 18 cmH2O. The another subgroup performed unloaded breathing training at the loaded of 0 cmH2O. Breathing frequency will be control at 6 breaths/minute in both subgroups. The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
Data collection will be carried out for 4 times: (1) before control, (2) before training, (3) after training and (4) after stop training. All measurement will be done in the cardiovascular laboratory room, department of physical therapy, faculty of associated medical sciences. In addition, self measurement of blood pressure and heart rate will be conducted at home every morning after getting up at the same time throughout the study (from week 0 to 18).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Khon Kaen
-
Muang, Khon Kaen, Thailand, 40000
- Faculty of Associated Medical Science, Khon Kaen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Essential isolated systolic hypertension (stage I- II, based on recommendations of JNC-VII)
- Good communication
Exclusion Criteria:
- Essential hypertension stage III or secondary hypertension
- History of respiratory disease, heart disease, renal disease, blindness, deafness and cerebrovascular disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Placebo
The breathing was performed normally in this groups.
|
7 days/week, for 8 weeks
|
Experimental: Loaded breathing training
subjects will trained to inspire deeply against the resistance setting by using BreathMAX® at the loaded of 18 cmH2O with breathing frequency control at 6 breaths/minute.
Breathing pattern will be controlled at duty cycle of 0.4 (inspiratory time = 4 sec and total respiratory time = 10 sec).
The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
|
7 days/weeks, for 8 weeks
|
Experimental: Unloaded breathing training
subjects will trained to inspire deeply (no resistance) with breathing frequency control at 6 breaths/minute.
Breathing pattern will be controlled at duty cycle of 0.4 (inspiratory time = 4 sec and total respiratory time = 10 sec).
The training program will be performed at home for 30 minutes/day, 7 days/week for 8 weeks.
|
7 days/week, for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Resting blood pressure
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Heart rate
Time Frame: 4 months
|
4 months
|
Pulse wave velocity
Time Frame: 4 months
|
4 months
|
Exercise pressure response
Time Frame: 4 months
|
4 months
|
Heart rate variability
Time Frame: 4 months
|
4 months
|
cardiac output
Time Frame: 4 months
|
4 months
|
Flow-mediated dilatation of brachial artery
Time Frame: 4 months
|
4 months
|
Forearm limb blood flow
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Benjarat Sangthong, M.Sc., Faculty of associated medical science, Khon Kaen University, thailand
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BSangthong
- change1me (Registry Identifier: Benjarat Sangthong)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systolic Essential Hypertension
-
University of IowaRecruitingHypertension, Systolic | Stiffness, AorticUnited States
-
Orchestra BioMed, IncMedtronicRecruitingHypertension | Hypertension, Systolic | Hypertension,EssentialUnited States, Czechia, Hungary
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedIsolated Systolic HypertensionGermany
-
Nina HermansUniversity Hospital, AntwerpRecruiting
-
BackBeat Medical IncRecruitingHypertension,Essential | Systolic HypertensionPoland, Czechia, Hungary
-
NovartisCompletedEssential HypertensionFrance
-
Marshall UniversityRecruitingPregnancy Related | Cardiac Output, Low | Systolic Hypertension | Cardiac Output, High | Diastolic HypertensionUnited States
-
Weill Cornell Medical College in QatarHamad Medical Corporation; Case Western Reserve UniversityRecruitingMetabolic Syndrome | Hypertension, SystolicQatar
-
Seoul National University HospitalRecruitingHypertension | Obstructive Sleep Apnea | Prehypertension | Blood Pressure | Essential Hypertension | Systolic Hypertension | Diastolic HypertensionKorea, Republic of
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States